BioGaia

Share Issue/Capital Change • Sep 30, 2010

Press release 30 September 2010

Number of shares in BioGaia

As earlier published as of September 2, 2010, redemption of warrants during September has led to an increase of BioGaia's share capital by SEK 60,400 to a total of SEK 17,270,962.

The number of shares has increased with 60,400 class B-shares through which the number of class B-shares now amounts to 16,530,294 with no change in the number of class A-shares, i.e. 740,668.

The total number of shares is thereby today, the last trading date of the month, 17 270 962 shares which is equivalent to 23,936,974 votes.

For additional information contact: Peter Rothschild, President BioGaia Tel: 08-555 293 00 Margareta Hagman, Executive President BioGaia, Tel: 08-55529300

Latest press releases from BioGaia: 2010-09-23 BioGaia and SCA sign collaboration agreement 2010-09-02 Redemption of warrants 2010-08-17 Interim report 1 January – 30 June 2010

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm.

www.biogaia.com